Table 2. Final cellular graft... | American Society of Hematology

Table 2.

Final cellular graft composition (n = 16)

	Stem cell product			SD product
	Dose			Dose	Fraction^*
Patient ID	CD34⁺, × 10⁶/kg	CD3⁺, × 10⁴/kg	CD3⁺, × 10⁸/kg	CD4⁺, %	CD8⁺, %	CD56⁺, %	Other cells, %†
1	6.7	5.0	1.1	32.3	11.8	2.2	53.7
2	3.6	5.0	0.8	27.3	12.3	5.8	54.6
3	3.8	5.0	1.4	28.9	13.6	3.2	54.3
4	6.1	5.0	0.7	16.1	12.0	2.5	69.4
5	7.3	0.3	1.5	29.8	17.4	2.5	50.3
6	4.9	0.2	1.4	34.0	20.7	3.4	41.9
7	4.5	0.3	0.5	22.1	14.8	1.9	61.2
8	6.9	0.2	1.0	16.3	15.3	1.7	66.7
9	4.3	0.2	0.2	15.5	6.5	2.1	75.9
10	3.4	0.2	1.1	29.8	10.0	4.3	55.9
11	5.9	0.1	1.0	20.2	19.5	1.8	58.5
12	4.5	0.2	1.4	32.0	10.2	8.1	49.7
13	4.1	0.2	0.7	NA	NA	3.7	61.4
14	3.8	0.3	0.7	31.4	12.1	1.9	54.6
15	3.5	0.1	0.9	41.7	18.5	6.0	33.8
16	4.5	0.1	1.2	26.9	8.7	5.0	59.4
Median	4.5	0.2	1.0	28.9	12.3	2.8	55.3

	Stem cell product			SD product
	Dose			Dose	Fraction^*
Patient ID	CD34⁺, × 10⁶/kg	CD3⁺, × 10⁴/kg	CD3⁺, × 10⁸/kg	CD4⁺, %	CD8⁺, %	CD56⁺, %	Other cells, %†
1	6.7	5.0	1.1	32.3	11.8	2.2	53.7
2	3.6	5.0	0.8	27.3	12.3	5.8	54.6
3	3.8	5.0	1.4	28.9	13.6	3.2	54.3
4	6.1	5.0	0.7	16.1	12.0	2.5	69.4
5	7.3	0.3	1.5	29.8	17.4	2.5	50.3
6	4.9	0.2	1.4	34.0	20.7	3.4	41.9
7	4.5	0.3	0.5	22.1	14.8	1.9	61.2
8	6.9	0.2	1.0	16.3	15.3	1.7	66.7
9	4.3	0.2	0.2	15.5	6.5	2.1	75.9
10	3.4	0.2	1.1	29.8	10.0	4.3	55.9
11	5.9	0.1	1.0	20.2	19.5	1.8	58.5
12	4.5	0.2	1.4	32.0	10.2	8.1	49.7
13	4.1	0.2	0.7	NA	NA	3.7	61.4
14	3.8	0.3	0.7	31.4	12.1	1.9	54.6
15	3.5	0.1	0.9	41.7	18.5	6.0	33.8
16	4.5	0.1	1.2	26.9	8.7	5.0	59.4
Median	4.5	0.2	1.0	28.9	12.3	2.8	55.3

NA indicates no T-cell subpopulation was available; the total T-cell fraction was 34.9%.

Each individual cell fraction is expressed as percentage of all viable cells in the SD product

Includes granulocytes, monocytes, and B cells (not presented separately)